Cathie Wood’s ARK sells AMD stock, buys Nvidia and Tesla

ARK Invest sold 181,767 AMD shares worth $110.5M while buying 356,681 Nvidia shares valued at $81.6M, signaling a notable rotation within its semiconductor and AI exposure. The firm also added $26.7M of Broadcom, $21.7M of CoreWeave and $17.3M of Tesla, while selling $38.5M of 10x Genomics and $10.9M of Tempus AI. The trades reflect continued positioning toward selected high-growth AI, semiconductor and EV names, but are primarily portfolio-flow news rather than a fundamental company catalyst.

Analysis

The disclosed activity is not independently informative on fundamentals; it is primarily a one-day flow signal from a concentrated, high-beta complex. The more actionable implication is technical: names with meaningful ARK ownership and smaller average daily liquidity can experience reflexive volatility if redemptions persist, while mega-cap semiconductor purchases are unlikely to alter their supply-demand balance. Avoid treating the AMD/NVDA rotation as a read-through on accelerator share; the relevant catalysts remain hyperscaler capex guidance, supply availability, and each company’s AI revenue conversion at the next earnings cycle.

Higher long-end yields are the more important transmission mechanism than the ETF trades. They compress terminal-value multiples for TSLA, CRWV, and pre-profit genomics/AI-healthcare equities disproportionately, while CRWV additionally faces a potentially higher cost of financing for capital-intensive infrastructure expansion. Within semis, AVGO offers a less duration-sensitive expression of AI spend than NVDA or AMD because custom silicon, networking, and software create a broader earnings base; the relative trade should work over 1-3 months if yields remain elevated and AI spending shifts from training concentration toward network and inference buildout.

Contrarian view: ARK’s public buying can attract short-term retail follow-through, but that is most likely to be monetizable in thin, high-short-interest holdings rather than liquid index constituents. A sustained rise in real yields would turn any such bounce into an opportunity to fade unprofitable growth, particularly where financing needs are recurring. This thesis is falsified by a meaningful decline in long-end real yields, or by earnings guidance showing AI revenue/capex conversion materially above current expectations.

Key Decisions for Investors

• No directional trade solely on the disclosed ARK activity; monitor 5-day fund flows and ownership concentration in CRWV, NTLA, VCYT, TWST, and TXG. Treat persistent redemptions as a liquidity-risk alert rather than a fundamental short signal.
• Initiate a 1-3 month long AVGO / short equal-dollar AMD pair on weakness, targeting AI infrastructure broadening while limiting sector-beta exposure. Risk: AMD delivers a major accelerator customer win or raises AI revenue outlook; exit on a decisive AMD guidance upgrade or if AVGO networking/custom-silicon commentary weakens.
• Maintain an underweight or use put spreads in CRWV versus an AI-semiconductor basket over the next 3 months if long-end yields remain elevated. The asymmetric risk is funding and depreciation pressure against a capex-heavy model; cover if financing terms improve materially or backlog/revenue conversion exceeds expectations for two consecutive reporting periods.
• Avoid adding TSLA purely on flow-driven strength; use any near-term rally to reassess exposure ahead of delivery and automotive-margin catalysts. A sustained easing in real yields and demonstrable improvement in vehicle gross margin would invalidate the duration-risk caution.